Wellbutrin: A Clinically Proven Antidepressant for Symptom Relief
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.22 | $66.62 (0%) | 🛒 Add to cart |
| 60 | $1.97 | $133.25 $118.10 (11%) | 🛒 Add to cart |
| 90 | $1.88 | $199.87 $169.59 (15%) | 🛒 Add to cart |
| 120 | $1.84 | $266.49 $221.07 (17%) | 🛒 Add to cart |
| 180 | $1.80 | $399.74 $324.03 (19%) | 🛒 Add to cart |
| 270 | $1.77 | $599.60 $478.47 (20%) | 🛒 Add to cart |
| 360 | $1.76
Best per pill | $799.47 $632.92 (21%) | 🛒 Add to cart |
Wellbutrin (bupropion hydrochloride) is an atypical antidepressant medication belonging to the aminoketone class, distinct from commonly prescribed selective serotonin reuptake inhibitors (SSRIs). It is primarily indicated for the treatment of major depressive disorder (MDD) and seasonal affective disorder (SAD), and is also FDA-approved as an aid to smoking cessation treatment. Its unique neurochemical profile, primarily acting as a norepinephrine–dopamine reuptake inhibitor (NDRI), offers a favorable side effect profile for many patients, particularly regarding sexual function and weight gain, which are common concerns with other antidepressant classes. This makes it a valuable therapeutic option both as a monotherapy and as an adjunctive treatment in complex cases.
Features
- Active Ingredient: Bupropion hydrochloride.
- Available Formulations: Immediate-release tablets (75 mg, 100 mg), sustained-release (SR) tablets (100 mg, 150 mg, 200 mg), and extended-release (XL) tablets (150 mg, 300 mg).
- Pharmacologic Class: Aminoketone; Norepinephrine–Dopamine Reuptake Inhibitor (NDRI).
- Mechanism of Action: Believed to exert its antidepressant effect by inhibiting the neuronal reuptake of dopamine and norepinephrine, with minimal impact on serotonin reuptake.
- Prescription Status: Available by prescription only.
Benefits
- Effective Symptom Reduction: Demonstrated efficacy in alleviating the core symptoms of major depression, including low mood, anhedonia (loss of interest or pleasure), and feelings of worthlessness.
- Favorable Metabolic Profile: Associated with neutral or modest weight loss in many patients, unlike many other antidepressants which can cause significant weight gain.
- Minimal Sexual Dysfunction: Its NDRI mechanism is not typically associated with the treatment-emergent sexual side effects (e.g., decreased libido, anorgasmia, erectile dysfunction) commonly seen with SSRIs and SNRIs.
- Adjunctive Therapy Potential: Can be effectively combined with other antidepressants, particularly SSRIs, to enhance overall efficacy and mitigate SSRI-induced sexual side effects (often referred to as “bupropion augmentation”).
- Dual Indication: Provides treatment for both major depressive disorder and aids in smoking cessation, addressing two significant public health concerns.
- Activating Properties: Its dopaminergic and noradrenergic activity can help improve energy, focus, and motivation, which are often impaired in depression.
Common use
Wellbutrin is FDA-approved for the treatment of major depressive disorder (MDD) and for preventing major depressive episodes in patients with seasonal affective disorder (SAD). It is also approved as an aid to smoking cessation treatment. Off-label, it is sometimes used to treat attention-deficit/hyperactivity disorder (ADHD) and to counteract sexual dysfunction caused by other antidepressants.
Dosage and direction
Dosage must be individualized by a healthcare provider based on the patient’s clinical response and tolerance.
- Major Depressive Disorder (MDD):
- Immediate-Release: Initial dose is 100 mg twice daily. May be increased to 100 mg three times daily. Dosing should be at least 6 hours apart. Maximum dose is 450 mg per day.
- Sustained-Release (SR): Initial dose is 150 mg once daily in the morning. May be increased to 150 mg twice daily, with doses at least 8 hours apart. Maximum dose is 400 mg per day.
- Extended-Release (XL): Initial dose is 150 mg once daily in the morning. May be increased to 300 mg once daily. Maximum dose is 450 mg per day.
- Seasonal Affective Disorder (SAD): Treatment typically uses the XL formulation, initiated in the autumn prior to the onset of depressive symptoms. Dosing is 150 mg once daily in the morning, which may be increased to 300 mg once daily after one week.
- Smoking Cessation: Using the sustained-release formulation, dosing begins at 150 mg once daily for 3 days, then increases to 150 mg twice daily for 7–12 weeks. Doses should be taken at least 8 hours apart.
The tablet should be swallowed whole and not crushed, chewed, or divided, as this can lead to rapid dose release and increase the risk of seizure.
Precautions
- Seizure Risk: Wellbutrin is associated with a dose-dependent risk of seizure. This risk is significantly increased in patients with a history of seizure disorder, eating disorders (e.g., bulimia or anorexia nervosa), or those undergoing abrupt discontinuation of alcohol or sedatives.
- Hypertension: Periodic blood pressure monitoring is recommended, as treatment can elevate blood pressure in some patients.
- Hepatic Impairment: Use with extreme caution and at reduced dosage in patients with severe hepatic cirrhosis.
- Renal Impairment: Use with caution in patients with renal impairment.
- Activation of Mania/Hypomania: Antidepressants can precipitate a manic or hypomanic episode in patients with bipolar disorder. Screening for bipolar disorder is essential prior to initiation.
- Suicidality: All antidepressants carry a black box warning for increased risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18-24) during initial treatment. Patients of all ages must be monitored closely for clinical worsening, suicidality, or unusual changes in behavior.
- Angle-Closure Glaucoma: Has been associated with incidents of angle-closure glaucoma.
Contraindications
Wellbutrin is contraindicated in patients with:
- A seizure disorder or history of seizures.
- A current or prior diagnosis of bulimia or anorexia nervosa.
- Abrupt discontinuation from alcohol or sedatives (e.g., benzodiazepines, barbiturates).
- Known hypersensitivity or allergy to bupropion or any component of its formulation.
- Use of a monoamine oxidase inhibitor (MAOI) currently or within the preceding 14 days. Initiating an MAOI is contraindicated for at least 14 days after discontinuing Wellbutrin.
Possible side effect
Common side effects (often dose-related and may subside with continued use) include:
- Dry mouth
- Nausea, vomiting, constipation
- Headache
- Insomnia
- Dizziness
- Tremor
- Excessive sweating
- Agitation, anxiety
- Tinnitus
- Rash
- Weight loss
Serious side effects requiring immediate medical attention include:
- Seizure
- Severe allergic reaction (e.g., hives, itching, swelling, difficulty breathing)
- Hallucinations, paranoia, confusion
- Irregular heartbeat, chest pain
- Severe headache, blurred vision, pounding in the neck or ears (symptoms of hypertension)
- New or worsening mental health symptoms (e.g., anxiety, panic attacks, aggression, impulsivity, suicidality)
Drug interaction
Wellbutrin is primarily metabolized by the liver enzyme CYP2B6. Concomitant use with other medications can lead to significant interactions.
- Monoamine Oxidase Inhibitors (MAOIs): Contraindicated due to increased risk of hypertensive crisis.
- Other Antidepressants (e.g., SSRIs, TCAs, SNRIs): May increase the risk of serotonin syndrome; use with caution.
- Antipsychotics, Antidepressants, Systemic Corticosteroids, Tramadol: These drugs can lower the seizure threshold, potentially potentiating Wellbutrin’s own pro-convulsant effects.
- CYP2B6 Inhibitors (e.g., ticlopidine, clopidogrel): Can increase bupropion plasma levels and the risk of adverse effects.
- CYP2B6 Inducers (e.g., ritonavir, lopinavir, carbamazepine): Can decrease bupropion plasma levels, reducing its efficacy.
- Drugs Metabolized by CYP2D6 (e.g., beta-blockers, Type 1C antiarrhythmics, some SSRIs): Bupropion is a strong inhibitor of CYP2D6 and can increase plasma concentrations of these drugs.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is close to the time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Do not double the dose to make up for a missed one, as this significantly increases the risk of seizure.
Overdose
Overdose is a medical emergency. Symptoms are often severe and can include seizures, hallucinations, loss of consciousness, sinus tachycardia, and cardiac arrest. Fatal outcomes have been reported, especially with mixed overdoses involving other drugs. There is no specific antidote; management involves securing the airway and providing aggressive supportive care, including ECG monitoring and control of seizures with benzodiazepines.
Storage
Store at room temperature (20°C to 25°C or 68°F to 77°F), in a tightly closed container, away from light, excess heat, and moisture (i.e., not in a bathroom). Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or altering any treatment regimen. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- Clinical Evidence: Numerous randomized, double-blind, placebo-controlled trials have established the efficacy of bupropion for its approved indications. Meta-analyses consistently place it among effective first-line and second-line treatments for MDD.
- Expert Consensus: Wellbutrin is widely regarded by psychiatrists and clinicians as a cornerstone antidepressant, valued for its unique mechanism of action and favorable side effect profile regarding weight and sexual function. Its role in augmentation strategies is well-supported by clinical practice guidelines.
- Patient-Reported Outcomes: Many patients report positive experiences, specifically noting improvements in energy, motivation, and the absence of sexual side effects or weight gain commonly associated with other antidepressants. Individual experiences with efficacy and tolerability vary significantly.